Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ya-Ling Han

Showing results (51-60 of 219) with videos related to

Pageof 22
Sort By:
Journal of Geriatric Cardiology : JGC|October 18, 2013
Purification and functional assessment of smooth muscle cells derived from mouse embryonic stem cellsXiao-Xiang Tian, Jian Kang, Cheng-Hui Yan, et al.
Sheng Li Xue Bao : [Acta Physiologica Sinica]|August 15, 2006
[Over-expression of the cellular repressor of E1A-stimulated genes inhibits the apoptosis of human vascular smooth muscle cells in vitro.]Ya-Ling Han, Hong-Mei Xu, Jie Deng, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|June 4, 2005
[Coronary intervention in 1148 patients with chronic total coronary occlusion]Ya-ling Han, Jian Zhang, Quan-min Jing, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|June 1, 2005
[Percutaneous coronary intervention combined cardiac resynchronization therapy for refractory heart failure secondary to ischemic cardiomyopathy]Ya-ling Han, Hong-yun Zang, Dong-mei Wang, et al.
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue = Chinese Critical Care Medicine = Zhongguo Weizhongbing Jijiuyixue|September 10, 2004
[Protection of renal function during interventional diagnostic or therapeutic procedures in coronary heart disease patients complicated by chronic renal insufficiency]Ya-ling Han, Hong-yun Zang, Quan-min Jing, et al.
Chinese Medical Journal|July 26, 2006
Percutaneous coronary intervention for chronic total occlusion in 1263 patients: a single-center reportYa-ling Han, Shou-li Wang, Quan-min Jing, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|December 23, 2008
[Matrix metalloproteinase-1 gene -519A/G polymorphism and the risk of coronary heart disease in Northern Chinese Han population]Ya-Ling Han, Ze-Feng Wu, Xiao-Lin Zhang, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|December 24, 2010
[Effect of percutaneous coronary intervention timing and cilostazol use on left ventricular remodeling in patients with non-ST elevation myocardial infarction]Shou-li Wang, Fei Sun, Xin Zhao, et al.
Experimental and Therapeutic Medicine|December 20, 2019
Remote ischemic post-conditioning protects against myocardial ischemia/reperfusion injury by inhibiting the Rho-kinase signaling pathwayFeng Min, Xian Jie Jia, Qin Gao, et al.
Zhonghua Yi Xue Za Zhi|December 6, 2005
[Comparison of the effects of rapamycin-eluting stent implantation and coronary artery bypass grafting in treatment of patients with multi-vessel coronary disease]Ya-ling Han, Xiao-zeng Wang, Quan-min Jing, et al.
Pageof 22

Showing results (51-60 of 219) with videos related to

Sort By:
Pageof 22
Journal of Geriatric Cardiology : JGC|October 18, 2013
Purification and functional assessment of smooth muscle cells derived from mouse embryonic stem cellsXiao-Xiang Tian, Jian Kang, Cheng-Hui Yan, et al.
Sheng Li Xue Bao : [Acta Physiologica Sinica]|August 15, 2006
[Over-expression of the cellular repressor of E1A-stimulated genes inhibits the apoptosis of human vascular smooth muscle cells in vitro.]Ya-Ling Han, Hong-Mei Xu, Jie Deng, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|June 4, 2005
[Coronary intervention in 1148 patients with chronic total coronary occlusion]Ya-ling Han, Jian Zhang, Quan-min Jing, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|June 1, 2005
[Percutaneous coronary intervention combined cardiac resynchronization therapy for refractory heart failure secondary to ischemic cardiomyopathy]Ya-ling Han, Hong-yun Zang, Dong-mei Wang, et al.
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue = Chinese Critical Care Medicine = Zhongguo Weizhongbing Jijiuyixue|September 10, 2004
[Protection of renal function during interventional diagnostic or therapeutic procedures in coronary heart disease patients complicated by chronic renal insufficiency]Ya-ling Han, Hong-yun Zang, Quan-min Jing, et al.
Chinese Medical Journal|July 26, 2006
Percutaneous coronary intervention for chronic total occlusion in 1263 patients: a single-center reportYa-ling Han, Shou-li Wang, Quan-min Jing, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|December 23, 2008
[Matrix metalloproteinase-1 gene -519A/G polymorphism and the risk of coronary heart disease in Northern Chinese Han population]Ya-Ling Han, Ze-Feng Wu, Xiao-Lin Zhang, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|December 24, 2010
[Effect of percutaneous coronary intervention timing and cilostazol use on left ventricular remodeling in patients with non-ST elevation myocardial infarction]Shou-li Wang, Fei Sun, Xin Zhao, et al.
Experimental and Therapeutic Medicine|December 20, 2019
Remote ischemic post-conditioning protects against myocardial ischemia/reperfusion injury by inhibiting the Rho-kinase signaling pathwayFeng Min, Xian Jie Jia, Qin Gao, et al.
Zhonghua Yi Xue Za Zhi|December 6, 2005
[Comparison of the effects of rapamycin-eluting stent implantation and coronary artery bypass grafting in treatment of patients with multi-vessel coronary disease]Ya-ling Han, Xiao-zeng Wang, Quan-min Jing, et al.
Pageof 22